Market Cap (In CNY)
8.66 Billion
Revenue (In CNY)
2.17 Billion
Net Income (In CNY)
-420.05 Million
Avg. Volume
10.82 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 3.91-7.33
- PE
- -25.61
- EPS
- -0.23
- Beta Value
- 0.546
- ISIN
- CNE000001PY2
- CUSIP
- -
- CIK
- -
- Shares
- 1577481469.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Guorui Xu
- Employee Count
- -
- Website
- https://www.hisoar.com
- Ipo Date
- 2006-12-26
- Details
- Zhejiang Hisoar Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells fine chemicals and special raw drugs in China and internationally. It offers antibiotic, anti-virus, cardiovascular, sugar-reducing, and other materials; and medicine intermediates, and other customized and processed products, such as clindamycin, 4-AA Iso-carbapenem series, thiamphenicol, florfenicol, voglibose, eclindamycin, 4-AA iso-carbapenem, thiamphenicol, florfenicol, voglibose, etc. It also exports its products. The company was founded in 1966 and is based in Taizhou, China.
More Stocks
-
GLEMJ Gleeson plc
GLE
-
THRL
-
GRPLTDGRP Limited
GRPLTD
-
RWA
-
TEAMLEASETeamLease Services Limited
TEAMLEASE
-
THYROCAREThyrocare Technologies Limited
THYROCARE
-
SAKHTISUGSakthi Sugars Limited
SAKHTISUG
-
INS